Selective Energy Dysfunction: The CNS-Dependency Hypothesis
While the preceding sections document energy production impairment across multiple tissues, emerging evidence suggests ME/CFS may not represent global cellular energy failure but rather selective dysfunction affecting primarily CNS-dependent and demand-responsive processes while sparing genuinely autonomous, locally-controlled peripheral functions.
ME/CFS involves selective impairment of CNS-dependent and demand-responsive processes while sparing genuinely autonomous, locally-controlled peripheral functions (hair follicle cycling, basal cardiac automaticity, resting renal clearance). This pattern suggests either primary brain energy dysfunction affecting downstream coordination, or failure of demand-response coupling mechanisms, rather than uniform global cellular energy failure.
Cerebral blood flow during orthostatic challenge exemplifies this selectivity: 91% of patients with normal resting hemodynamics show abnormal CBF reduction during demand , while baseline perfusion is often preserved. Brain hypometabolism has also been documented , though replication remains incomplete (see Chapter Neurological and Neurocognitive Dysfunction Section Sleep EEG Delta/Alpha Ratio as a Non-Invasive Thalamic Calcium Proxy). Together, these findings support coordination failure rather than global energy deficit as the underlying pathophysiology.
Peripheral biomarker dissociation. Omdal et al. (2026) demonstrated this selective-dysfunction pattern directly: 48 long-COVID patients exhibited severe fatigue (fVAS median 63 vs 5 in recovered controls, FACIT-F 21.5 vs 49, p < 0.001) with zero differences in CRP, TNF-α, IL-6, HSP90α, Serpin F1, hémopexine, or APOA4 — confirming that disabling fatigue can persist without detectable systemic inflammation (Omdal et al. 2026). This dissociation is not a negative result; it is positive evidence that fatigue is driven by CNS-confined or non-inflammatory mechanisms (neuroinflammation compartmentalized behind the BBB, epigenetic maintenance of microglial activation, or mitochondrial-derived danger signals trapped in the CNS). The implication for the Selective Energy Dysfunction hypothesis is direct: normal peripheral inflammatory markers do not exclude CNS pathology, and the “normal results” paradox in ME/CFS clinical workup is a predictable feature of a compartmentalized disease rather than evidence against biological causation.
Certainty: 0.40. Supported by documented T cell metabolic dysfunction in ME/CFS and the established bioenergetic requirements of cytotoxic killing. However, the causal link between immune cell energy deficit and viral persistence has not been directly tested in ME/CFS.
This hypothesis proposes that the mitochondrial dysfunction documented in ME/CFS immune cells is not merely a symptom but a cause of viral persistence: metabolically impaired T cells and NK cells lack sufficient ATP to sustain cytotoxic function, creating a permissive niche where virus-harbouring cells survive despite immune recognition. This generates a self-reinforcing trap: viral persistence → chronic immune activation → T cell exhaustion and metabolic failure → inadequate viral clearance → more persistence.
Mechanistic Basis. Cytotoxic killing is among the most energy-intensive immune functions: degranulation, perforin pore formation, and granzyme delivery each require substantial ATP. Mandarano et al. demonstrated that ME/CFS CD8+ T cells fail to switch from oxidative phosphorylation to glycolysis upon activation (the Warburg effect) . Without this metabolic reprogramming, effector function is impaired even if the cell correctly recognizes its target. The Kol et al. FIP data provide indirect support: antiviral treatment reduced viral load but did not eliminate virus from lymphocytes, suggesting host immunity is needed for final clearance—and if that immunity is metabolically compromised, clearance never completes.
Testable Predictions.
- In vitro supplementation with metabolic support (D-ribose, CoQ10, or mitochondria-targeted antioxidants such as MitoQ) will restore ME/CFS NK cell and CD8+ T cell cytotoxic function in killing assays against virus-infected target cells.
- ME/CFS patients on combined antiviral + metabolic support therapy will show greater viral clearance (measured by pathogen-specific PCR or T-SPOT) than patients on antiviral therapy alone.
- The degree of T cell metabolic impairment (measured by Seahorse metabolic flux analysis) will inversely correlate with viral clearance efficiency in longitudinal studies.
- Patients with the most severe NK cell metabolic dysfunction will show the highest persistent viral antigen levels.
Falsifiability. This hypothesis would be falsified if (a) restoring immune cell metabolism via in vitro supplementation does not improve cytotoxic function against virus-infected targets, or (b) ME/CFS patients with documented viral persistence show normal immune cell bioenergetics. It would also be weakened if antiviral monotherapy achieves complete viral clearance without metabolic support, suggesting the energy deficit is not rate-limiting for clearance.
Treatment Implications. If confirmed, this hypothesis argues that antiviral therapy alone is insufficient—it must be combined with metabolic support targeting immune cell mitochondria. This reframes mitochondrial supplementation (CoQ10, NAD+ precursors, D-ribose) not merely as energy support for the patient, but as immune-enabling therapy that restores the body’s ability to clear persistent infection. It also provides mechanistic rationale for the Selective Energy Dysfunction hypothesis (Hypothesis Selective Energy Dysfunction): immune surveillance is a demand-responsive, CNS-coordinated process that fails under energy constraint.
Limitations. The hypothesis assumes viral persistence is a primary driver in a substantial proportion of ME/CFS cases, which may not hold for non-viral-onset subgroups. The in vitro prediction (metabolic supplementation restoring killing) may not translate to in vivo efficacy due to bioavailability and tissue distribution constraints. The self-reinforcing loop makes it difficult to determine which arm (metabolic failure or viral persistence) is primary.
1 Evidence for Selectivity
The distinction between preserved and impaired processes follows a consistent pattern:
Impaired Processes (CNS-Dependent + Demand-Responsive)
- Voluntary muscle exertion: Requires motor cortex coordination + scaling to demand
- Cognitive effort: Inherently CNS-based + scales with task complexity
- Orthostatic adaptation: Requires autonomic coordination + responds to positional demand
- Adaptive immune responses: Requires CNS-immune signaling + scales to antigen challenge
- Temperature regulation: Requires hypothalamic coordination + responds to environmental demands
Apparently Preserved Processes (Autonomous + Locally Controlled)
Clinical observation suggests the following autonomous, locally-controlled processes continue at apparently normal rates in ME/CFS despite severe systemic symptoms:
- Hair follicle cycling: Operates independent internal Cori cycle; no CNS coordination required
- Nail growth: Locally controlled keratin synthesis
- Baseline cellular metabolism: Homeostatic processes not requiring demand scaling
- Basal cardiac automaticity: SA node pacing is intrinsic and does not require CNS input
- Resting renal clearance: Glomerular filtration at rest is pressure-driven, not CNS-coordinated
- Hepatic constitutive enzyme expression: Phase I detoxification operates at constitutive baseline without demand scaling
Formal documentation of these observations is lacking in the ME/CFS literature, representing a gap requiring systematic validation. However, their apparent preservation contrasts markedly with profound impairment of CNS-coordinated demand-responsive functions.
Wound healing is excluded from the preserved category. Although wound healing might appear to be an autonomous local process, it is in fact a complex, multi-phase, demand-responsive cascade (hemostasis → inflammation → proliferation → remodeling) requiring NK cell mobilization, autonomic vascular regulation, fibroblast activation, angiogenesis, and significant mitochondrial ATP. No study has directly measured wound healing in ME/CFS patients. Mechanistic evidence from three independent pathways — each based on single studies with important caveats — suggests abnormal wound healing dynamics rather than normal preservation:
- NK cell dysfunction pathway: NK cell cytotoxicity is reduced in ME/CFS (Hedges’ \(g = 0.96\), 95% CI: 0.75–1.18, 28 studies ). Sobecki et al. showed that NK cells regulate wound healing through IFN-γ and GM-CSF secretion under hypoxia — but the relevant NK function is cytokine output, not cytotoxicity per se, and these are distinct functional properties regulated by different signaling pathways . Furthermore, Sobecki’s mechanism predicts that reduced NK output produces faster initial closure at the cost of impaired immune coordination — abnormal healing dynamics rather than simple delay. Whether this mechanism operates in normoxic cutaneous wounds, and whether cytotoxicity reduction in ME/CFS (the measured quantity) corresponds to reduced wound-relevant cytokine secretion (the mechanistically required quantity), are both assumed, not demonstrated.
- Autonomic dysregulation pathway: Sympathetic overactivation directly inhibits reepithelialization and shifts macrophage polarization toward anti-repair in a mouse corneal model . Whether tissue-level catecholamine concentrations in ME/CFS patients reach the inhibitory threshold used in the Xue model is unknown — ME/CFS dysautonomia manifests in systemic HRV and postural tachycardia markers, and local tissue sympathetic tone at wound sites is uncharacterized.
- Immune exhaustion pathway: The immune exhaustion phenotype in burn patients produces clinically documented wound healing impairment . However, burn-induced immune exhaustion involves massive cytokine storm, systemic protein loss, and global ischemia — a far more extreme model than ME/CFS. The validity of downward generalization from this extreme to the milder ME/CFS immune phenotype is not established.
Each pathway has substantial caveats; if any single caveat is fatal, the remaining two pathways carry the prediction alone. Whether ME/CFS patients actually experience abnormal wound healing remains an unstudied question, and minor wound repair may remain functionally autonomous even if complex wound healing is impaired. The assumption of preservation is unsupported, but so is the prediction of impairment — direct measurement is needed to resolve the question (see Section Is Wound Healing Actually Impaired in ME/CFS?).
Critical Implication If ME/CFS were global mitochondrial dysfunction, all energy-requiring processes — including hair growth — should be affected proportionally. The preservation of truly autonomous peripheral processes suggests the pathology may lie in energy coordination and allocation rather than energy production capacity per se. The key criterion for “preserved” status is that a process must be genuinely autonomous and locally controlled, not merely slow or low-energy.
2 The Demand-Response Failure Pattern
A consistent finding across multiple physiological systems is preserved baseline function with impaired challenge response (Keller et al. 2024):
- Cardiovascular: Resting cardiac parameters often normal; profound dysfunction during orthostatic or exercise challenge (Section Near-Universal Vasopressin Deficiency in ME/CFS)
- Cognitive: Basic language comprehension preserved; executive function and working memory (high-demand) severely impaired (Walitt et al. 2024)
- Autonomic: Baseline HRV present; blunted response to physiological challenges
- Cerebral perfusion: 91% of patients with normal resting HR/BP show abnormal cerebral blood flow reduction during tilt testing
This pattern is consistent with intact energy production capacity but impaired ability to mobilize energy in response to demand—a coordination failure rather than a production failure.
3 Mechanistic Implications
The near-universal cognitive dysfunction and documented brain hypometabolism (Walitt et al. 2024) suggest CNS energy crisis may be the primary pathophysiological event. The brain consumes 20–25% of resting energy despite comprising only 2% of body mass (Section The Energy Chain: Ten Steps from Substrate to ATP), making it uniquely vulnerable to energy constraint. Failure of the brain to coordinate peripheral demand-responsive processes could explain the selective dysfunction pattern: autonomous processes continue because they don’t require CNS coordination, while CNS-coordinated responses (exercise capacity, orthostatic tolerance, cognitive effort) fail because the coordinating organ itself is energy-depleted.
This model explains why pharmacological bypass of autonomic coordination (midodrine, fludrocortisone) can partially restore orthostatic function—the peripheral targets respond when appropriately stimulated, suggesting the dysfunction is in coordination rather than peripheral capacity.
See Chapter Neurological and Neurocognitive Dysfunction Section Central Catecholamine Findings: Expanding Evidence, Remaining Gaps for expanded discussion of brain-centric pathophysiology, and Chapter Cardiovascular Dysfunction Section Near-Universal Vasopressin Deficiency in ME/CFS for cerebral blood flow evidence during orthostatic challenge.
4 Therapeutic Implications of Selective Dysfunction
If ME/CFS involves selective coordination failure rather than global energy production deficit, treatment strategies should prioritize:
CNS-targeted interventions: Compounds that cross the blood-brain barrier and support brain energy metabolism specifically, rather than systemic mitochondrial supplements that may not reach the CNS at therapeutic concentrations
Autonomic coordination bypass: Pharmacological agents that directly activate peripheral targets, bypassing impaired CNS signaling (e.g., midodrine for vasoconstriction, fludrocortisone for volume expansion, droxidopa for norepinephrine replacement)
Demand management: Strict pacing to remain within the envelope of available coordination capacity, rather than attempting to increase energy production through exercise or stimulants
This reframing suggests that failed trials of systemic energy supplements (CoQ10, carnitine, B-vitamins) may reflect inadequate CNS penetration rather than incorrect therapeutic targets. If brain energy coordination is the primary bottleneck, supplements that do not cross the blood-brain barrier at therapeutic concentrations would be expected to show limited efficacy regardless of their peripheral effects. This hypothesis is testable through comparative trials of CNS-penetrant versus non-penetrant formulations of the same compounds.
NETosis requires substantial NADPH oxidase activity, chromatin decondensation, and membrane remodeling—all energy-intensive processes. In a system where mitochondria already show stress-responsive failure (Cullen et al. 2026), ongoing NETosis (Krinsky et al. 2023) may act as a metabolic drain that competes with normal cellular energy demands. This creates a potential vicious cycle: energy depletion impairs NET clearance (DNase production requires cellular energy), accumulated NETs drive further inflammation, and inflammation increases energy demand.
Study: (mechanistic reasoning, certainty: 0.30, untested).
Sanhueza et al. (Sanhueza et al. 2026) demonstrated that 67% of patients without pre-existing glucose disorders developed de novo insulin resistance (IR) at 4 months post-COVID-19, and that insulin enhances NETosis independently of glucose concentrations in vitro. This establishes a direct metabolic-immune link: post-infectious IR drives neutrophil metabolic reprogramming toward sustained NET production through glycolysis-dependent pathways. In ME/CFS, where metabolic dysfunction including impaired glucose metabolism is documented (see sections above), IR could create a self-reinforcing loop: metabolic dysfunction → IR → enhanced NETosis → thrombo-inflammation → microvascular impairment → tissue hypoxia → worsened mitochondrial function → deeper metabolic dysfunction. This loop would be distinct from—and additive to—the ATP-depletion NETosis cycle described above, as IR-driven NETosis operates through Akt/mTOR signaling rather than energy substrate depletion per se, and may persist even when cellular ATP is adequate.
Certainty: 0.35. ME/CFS-extrapolation from COVID-19 data. Insulin resistance has been reported in ME/CFS but the causal relationship with NETosis is untested in this population.
Testable prediction: ME/CFS patients should show IR (HOMA-IR) correlating with NET remnant levels; metformin or insulin-sensitising interventions should reduce NET markers independently of glucose changes.
Exercise increases gut permeability (translocation of LPS and bacterial products into circulation) and sympathetic activation—both potent NETosis triggers. In individuals with underlying NET/DNase imbalance (reduced DNase activity, primed neutrophils), the post-exercise NET burden may exceed degradation capacity, producing a thrombo-inflammatory surge that amplifies and prolongs post-exertional malaise beyond the direct metabolic cost of the exercise itself. This “NET amplification” model of PEM explains why brief, low-intensity exertion can produce multi-day symptom exacerbations: the NET burden is not proportional to exercise duration (minutes of exertion → hours of NETosis → days of clearance). The model also predicts delayed-onset PEM: NET formation peaks 2–4 hours after stimulation, consistent with the PEM latency documented in ME/CFS.
Certainty: 0.25. No exercise-NETosis data exist in ME/CFS. Exercise-induced NETosis is well-documented in healthy populations but the PEM amplification hypothesis is untested.
Testable prediction: ME/CFS patients should show elevated NET markers (MPO-DNA, H3cit) at 4–24h post-CPET, correlating with PEM severity; healthy controls should show minimal or no NET elevation.
The “selective vs. global” energy dysfunction distinction rests on clinical observation that hair growth, nail growth, and other autonomous processes are preserved in ME/CFS. Formal documentation of these preserved processes is lacking — the claim derives from patient self-reports and clinical impression, not from controlled measurement. Processes classified as “preserved” also have much lower absolute energy demands than those classified as “impaired,” meaning a moderate global energy deficit could produce the same clinical pattern without any selectivity mechanism.
Wound healing — previously listed among preserved processes — has been removed from this framework. Wound healing is a complex, multi-phase, demand-responsive cascade requiring NK cell mobilization, autonomic regulation, and substantial energy expenditure. No study has measured wound healing in ME/CFS patients, and mechanistic evidence from three independent pathways — NK cell dysfunction , sympathetic overactivation , and immune exhaustion — each based on single studies with substantial caveats (see above), suggests abnormal healing dynamics rather than normal preservation. This correction improves the mechanistic coherence of the framework by restricting the “preserved” category to genuinely autonomous, locally-controlled, steady-state processes, though the preserved status of the remaining items (hair growth, nail growth) itself remains based on patient self-reports without formal measurement.
For quantitative analysis of this alternative explanation, see the selective dysfunction framework in Section Selective Energy Dysfunction Hypothesis.
See Part III for detailed treatment protocols, particularly Chapter Medications Targeting Underlying Mechanisms for pharmacological approaches and Chapter Symptom-Based Management for symptom-specific interventions.
No study has directly measured wound healing rate, quality, or complication frequency in ME/CFS patients. Mechanistic evidence from NK cell dysfunction , autonomic dysregulation , immune exhaustion , and chronic TGF-β elevation disrupting NK-MSC wound repair circuits predicts impairment — though each pathway is based on single studies and extrapolation to ME/CFS is inferential. However, patients and clinicians have not reported wound healing as a prominent clinical complaint, creating an apparent discrepancy between mechanistic prediction and clinical observation. A further possibility is that sedentary, homebound patients simply encounter fewer wound-producing situations, making clinical silence uninformative about either preserved or impaired function.
Possible reconciliations: (1) subclinical impairment exists but is masked by the low wound burden of sedentary, homebound patients; (2) compensatory mechanisms (e.g., elevated TGF-β promoting fibrosis) produce apparently normal closure at the cost of scar quality; (3) wound healing is genuinely preserved through mechanisms not captured by the pathways studied. A controlled study comparing standardized wound healing rates (e.g., suction blister healing time) between ME/CFS patients and age-matched controls would resolve this question and directly test the selective energy dysfunction hypothesis.
If NK cells regulate wound healing through IFN-γ and GM-CSF secretion , and ME/CFS NK function is broadly impaired (noting that the measured quantity is cytotoxicity, while the wound-relevant function is cytokine secretion — a related but distinct property), then the repair deficit could extend beyond skin wounds to all NK-dependent tissue maintenance. This would predict impaired mucosal barrier repair (consistent with documented gut permeability in ME/CFS), slower muscle damage repair after exertion (contributing to prolonged PEM duration), and impaired vascular endothelial repair (consistent with endothelial dysfunction in Chapter Cardiovascular Dysfunction). These phenomena are currently treated as separate pathophysiological findings with separate explanations (mast cell activation for gut permeability, metabolic failure for PEM, oxidative stress for endothelial dysfunction); this hypothesis proposes a complementary upstream cause — halved NK repair function — that could contribute to all three. It does not claim to replace the existing explanations but suggests an additional mechanism that may compound them.
Falsifiable prediction: Gut mucosal repair rate (measured by serial lactulose-mannitol permeability tests after standardized challenge) should correlate with NK cytokine secretion capacity (stimulated IFN-γ and GM-CSF output from PBMCs, \(r > 0.4\)) in ME/CFS patients after controlling for overall disease severity (Bell score). Note: the prediction requires measuring NK cytokine output specifically, not NK cytotoxicity — which is a related but distinct functional property — to test the Sobecki wound-repair mechanism.
Certainty: 0.40 — strong mechanistic chain from Sobecki 2021 and Baraniuk 2024, but multiple inferential steps; NK role in non-skin tissue repair is less established than in skin. Not yet replicated in ME/CFS context.
Xue et al. identified two macrophage populations with opposing wound healing effects: CD64+CCR2+ (β2-adrenergic, SNS-responsive, pro-inflammatory, anti-repair) and CD64+CCR2- (α7-nAChR, PNS-responsive, anti-inflammatory, pro-repair) . ME/CFS is characterized by sympathetic overactivation and parasympathetic withdrawal (Chapter Cardiovascular Dysfunction). If this systemic autonomic imbalance translates to altered tissue-level sympathetic tone (an assumption — ME/CFS dysautonomia is characterized by systemic markers such as HRV and postural tachycardia, but local tissue sympathetic nerve activity is uncharacterized), it would favour the pro-inflammatory, anti-repair macrophage phenotype across tissues — not only skin wounds but also brain (neuroinflammation suggested by PET markers , consistent with M1-biased microglial polarization though direct polarization data in ME/CFS is lacking), gut (intestinal macrophage polarization toward barrier-disrupting), and muscle (impaired satellite cell activation after exertion).
This creates a potential unifying mechanism: autonomic dysfunction → macrophage polarization bias → impaired tissue repair across organs. The effectiveness of vagus nerve stimulation and beta-blockers in some ME/CFS patients (Chapter Emerging and Investigational Therapies) may partly reflect restoration of repair-permissive macrophage polarization, not only anti-inflammatory effects.
Falsifiable prediction: ME/CFS patients with higher sympathetic tone (lower HRV, higher resting HR, more severe POTS) should show slower wound healing, more neuroinflammation (PET ligand binding), and worse gut permeability, all correlating with the same autonomic measure.
Certainty: 0.45 — multiple independent lines support the ANS-macrophage link; direct ME/CFS tissue macrophage polarization data is lacking. Not yet replicated.
Beyond autonomic macrophage polarization, a 2026 conference abstract provides the first direct evidence that the satellite cell pool itself is depleted in ME/CFS and Long COVID skeletal muscle (Charlton et al. 2026). Satellite cells (Pax7⁺ muscle stem cells) are the cellular substrate for muscle repair — their depletion means that even if macrophage polarization and NK-mediated repair signalling were normal, the muscle would lack the cellular machinery to regenerate damaged fibres. Fibroadipogenic progenitor (FAP) cells, which provide essential niche support for satellite cell proliferation and differentiation (Yin, Price, and Rudnicki 2013), showed a trending reduction (PDGFRα⁺, P=0.061) suggesting the regenerative niche itself is compromised.
The positive correlation between satellite cell count and OXPHOS capacity (r=0.43, P=0.0035) (Charlton et al. 2026) links this finding to the energy metabolism chapter’s central thesis: mitochondrial dysfunction is not only an ATP production problem — it directly gates tissue regeneration capacity. Satellite cell activation, proliferation, and differentiation all require OXPHOS (Bhattacharya and Scimè 2024). The metabolic shift away from oxidative metabolism and reduced antioxidative metabolites found in the same biopsies suggest that the satellite cell niche is metabolically hostile to regeneration.
This creates a convergent model: autonomic dysfunction biases macrophage polarization toward anti-repair (as above); NK cell dysfunction impairs repair cytokine secretion (NK-mediated tissue repair deficit, Systemic Tissue Repair Deficit: NK Cells as Repair Coordinators Beyond Skin); mitochondrial failure blocks satellite cell differentiation; and satellite cell depletion removes the cellular substrate for repair entirely. Each mechanism is individually speculative, but together they describe a multi-layered tissue repair crisis that could drive cumulative, poorly-repaired muscle damage with repeated exertion.
Caution: satellite cell depletion was observed at baseline (not only post-exertion) in the Charlton 2026 abstract (Charlton et al. 2026) — the finding is equally consistent with an exertion-independent depletion mechanism. The exertion→damage→failed-repair causal chain is plausible but unproven.
Certainty: 0.37 — built on a conference abstract (unreplicated, single biobank); the convergence of the autonomic, NK, mitochondrial, and satellite cell lines is hypothesis-level only.
Falsifiable prediction: In ME/CFS patients, the correlation between satellite cell count and PEM severity (measured by DSQ-PEM score or CPET Day 1→Day 2 work reduction) should be significantly stronger than the correlation between satellite cell count and fatigue severity — i.e., SC depletion predicts PEM specifically, not just global illness severity.
Consequence: If the multi-layered repair failure model is correct, no single intervention (autonomic modulation, NK enhancement, mitochondrial support, or satellite cell protection) will be sufficient alone — the repair deficit is overdetermined. Combination strategies targeting multiple layers simultaneously may be necessary.
The comparable satellite cell depletion in both ME/CFS (pre-pandemic onset) and Long COVID (post-SARS-CoV-2) (Charlton et al. 2026) suggests a convergent post-infectious mechanism rather than a virus-specific effect. This convergence is also seen in the microvascular findings from the same cohort (Charlton et al. 2025). Potential shared mechanisms include: 1. Persistent interferon signalling — type I IFN directly suppresses satellite cell proliferation and promotes quiescence 2. Autoantibody formation — anti-GPCR autoantibodies (β-adrenergic, muscarinic receptors) documented in both conditions could disrupt satellite cell niche function, though this has not been tested in satellite cells or FAPs specifically 3. Metabolic reprogramming — shared OXPHOS impairment → satellite cell metabolic insufficiency → exhaustion 4. Chronic oxidative stress — reduced antioxidative metabolites in both groups → satellite cell niche degradation
The critical open question is whether satellite cell depletion is irreversible. In aging, satellite cell function declines and recovery capacity becomes limited — but aging-driven senescence is mechanistically distinct from inflammation- or metabolism-driven SC suppression, which may be reversible. If ME/CFS SC depletion shares aging-like irreversibility mechanisms, then interventions must focus on preventing further loss (protecting remaining satellite cells) rather than restoring the pool — a fundamentally different therapeutic strategy.
Consequence: The practical implication diverges sharply by mechanism — if SC depletion is reversible (suppression-driven, secondary to inflammation/OXPHOS failure), treating the underlying drivers could restore regeneration capacity over time. If it is irreversible (senescence-driven or SC pool permanently exhausted), the priority shifts from restoration to protection of remaining SCs. The wrong assumption wastes precious patient energy on interventions targeting the wrong mechanism.
Falsifiable predictions: (1) If persistent type I interferon signalling drives SC suppression, muscle tissue IFN signatures should be elevated in both ME/CFS and LC patients compared to recovered post-infectious controls, and should correlate inversely with SC count. Absence of such correlation would falsify the IFN-mediated SC suppression pathway. (2) If SC depletion is irreversible, patients whose systemic inflammation or OXPHOS dysfunction normalises after an effective intervention should NOT show SC count recovery on repeat biopsy; SC count recovery would falsify the irreversibility claim.
5 Subtype Considerations
The selective dysfunction pattern may manifest differently across patient subgroups. Some patients show primarily CNS-energy deficit (cognitive and autonomic symptoms predominating with relatively preserved peripheral muscle function), while others show primarily peripheral demand-response failure (exercise intolerance and orthostatic symptoms with relatively preserved cognition at rest). These patterns may represent different points along a continuum or distinct pathophysiological subtypes requiring tailored interventions.
Formal subtype analysis based on the selective dysfunction framework is developed in Chapter Speculative Mechanistic Hypotheses Section Selective Energy Dysfunction Hypothesis, including quantitative predictions for dysfunction severity across processes based on their CNS-dependency and demand-responsiveness.